lobbying_activities: 2829228

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2829228	f5d58a5b-2269-44e9-bafc-acd875793e27	Q2	RUBICON ADVISORS, LLC	315091	AVET PHARMACEUTICALS	2022	second_quarter	PHA	GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES	30000		0	0	2022-07-19T11:57:13-04:00